Correlation between capsule endoscopy and fecal calprotectin levels in small bowel lesions of Crohn's disease
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000036319
- Lead Sponsor
- Fukuoka University Chikushi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Not provided
1. Patients with malignant tumor 2. Patients with acute abdomen 3. Patients with serious acute inflammation 4. Patients with pregnant woman 5. Patients who cannot be confirmed GI patency under patency capsule 6. Patient's general health is extremely poor, Patients who has risk for performing endoscopy such as ileus, perforation, pancreatitis, respiratory disorder, cardiovascular disorder, acquired hemophilia, stenosis, large ulcer, or tumor 7. Patients with active lesions in colon 8. Patients with stoma 9. Patients with history of abdominal surgery 10. Patients with habitual NSAIDs consumption 11. Colonic Crohn's disease 12. Patients used to participate in this trial 13. Also, patients who are judged not suitable for this trial by the doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between Lewis score of small bowel capsule endoscopy and fecal calprotectin
- Secondary Outcome Measures
Name Time Method 1. Correlation between fecal calprotectin and Alb, CRP, or ESR 2. Correlation between fecal calprotectin and HBI 3. Correlation between fecal calprotectin and CECDAI 4. Cleansing level of small bowel capsule endoscopy